Risk of serious bacterial infections in inflammatory rheumatic or bowel disease patients during biological therapies: nationwide Danish cohort study

Risk of serious bacterial infections in inflammatory rheumatic or bowel disease patients during biological therapies: nationwide Danish cohort study

Introduction To estimate the incidence rate ratio (IRR) of serious bacterial infections (SI) in patients with inflammatory bowel disease (IBD) or inflammatory rheumatic disease (IRD) before and after initiating biological therapy, and to assess comorbidities, infection sites, and the type of biologi...

Full description

Saved in:
Bibliographic Details
Main Authors: Emma Cathrine Højberg Platz, Gustav Emil Laugesen, Anne Ahrens Østergaard, Keld-Erik Byg, Inge Petersen, Isik Somuncu Johansen
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Annals of Medicine
Subjects:
bDMARDs
anti-TNF alpha
bacterial infections
IBD
RA
Online Access:https://www.tandfonline.com/doi/10.1080/07853890.2025.2522968
Tags: Add Tag
No Tags, Be the first to tag this record!
Login for hold and recall information

Internet

https://www.tandfonline.com/doi/10.1080/07853890.2025.2522968

Similar Items